A股異動丨馬斯克稱需求可能會達到100億台,機器人概念股繼續活躍,豐立智能、遠大智能2連板
格隆匯5月19日丨機器人概念股今日繼續活躍,豐立智能、遠大智能2連板,佰奧智能、中威電子、賽為智能、全志科技、鳴志電器、中大力德升超5%。特斯拉在2023年股東大會上,通過視頻展示了Optimus人形機器人最新進展,包括撿起物品、環境發現和記憶,基於AI模仿人類動作,能完成分類物品的複雜任務。特斯拉機器人取得全方位進展,運動控制能力持續進化,AI能力大幅提升。馬斯克對人形機器人市場充滿信心,甚至認為特斯拉未來長期價值可能都是Optimus給的。對於人形機器人的商品化和未來需求,馬斯克説:“ 我覺得這個需求也許可能會達到100億台,這是一個瘋狂的數字。”

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.